Cardiome Pharma Corp (NASDAQ:CRME)

1.43
BATS BZX Real-Time Price
As of 12:16pm ET
 +0.02 / +1.42%
Today’s Change
1.29
Today|||52-Week Range
4.84
-7.74%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Cardiome Pharma Corp have a median target of 5.45, with a high estimate of 9.50 and a low estimate of 2.80. The median estimate represents a +281.12% increase from the last price of 1.43.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Cardiome Pharma Corp. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.19
Sales
$8.1M
Reporting Date
Mar 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 3.75%
 
 
 
 
 
 
Growthannually -3.39%
 
 
 
 
 
 

Sales

Growthquarterly 34.12%
 
 
 
 
 
 
Growthannually -1.35%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.